Hutch News

Hutch News

Stories tagged 'glioblastoma'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 4, 2015 | By Fred Hutch News Service staff

Dr. Patrick Paddison and colleagues identify a potential Achilles' heel in brain tumor cells via genome editing.

View story >

Beau Biden's death highlights difficulty of treating brain cancers

Nearly 14,000 die each year of brain cancer, but researchers are aiming to change that

June 2, 2015 | By Bill Briggs and Dr. Sabrina Richards

The family of Joseph “Beau” Biden III, son of Vice President Joe Biden, has not yet revealed the specific type of brain cancer that killed the 46-year-old father and Iraq veteran on Saturday. Nearly 14,000 people die annually from brain cancer, but researchers at Fred Hutch are trying to change that.

View story >

Challenging the notion of personalized medicine

Study suggests effective brain cancer therapies should focus on early similarities between tumors rather than differences

Aug. 11, 2014 | By Dr. Sabrina Richards / Fred Hutch News Service

New brain cancer findings by scientists at Fred Hutchinson Cancer Research Center fly in the face of personalized medicine, which tailors treatment to a tumor’s unique genetic or molecular profile. Instead, the study suggests that effective brain cancer therapies should target the similarities between tumors rather than their differences.

View story >

‘Breakthrough’ treatment boosts survival in battle with deadly brain tumor

Fred Hutch scientists report early success with novel gene therapy to attack cancer while protecting healthy cells

Aug. 8, 2014 | By JoNel Aleccia / Fred Hutch News Service

Fred Hutch scientists report early success with novel gene therapy to attack cancer while protecting healthy cells.

View story >

Researchers eye altered radiation schedule as way to improve brain cancer treatment

Fred Hutch’s Dr. Eric Holland collaborates with Dana-Farber on promising mouse study

Feb. 6, 2014 | By Kristen Woodward

An altered radiation treatment schedule for the most common and lethal form of brain cancer has been shown to extend the survival period of mice with the disease, which suggests that some alteration in schedule may be able to do the same for human patients.

View story >

Galloway, Paddison, Eisenman land Provocative Questions grants

Fred Hutch investigators among first in nation to receive new National Cancer Institute awards to pursue novel, creative directions in cancer research

Oct. 29, 2012 | By Rachel Tompa

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.